US2019255097A1PendingUtilityA1
Treatment of alphavirus-induced inflammation
Est. expiryMay 26, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A61P 31/14A61K 9/0019A61K 31/737A61P 19/02A61P 29/00A61P 21/00Y02A50/30
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method of treating alphavirus infections, particularly in humans, in which pentosan polysulfate is administered to an infected subject. Whilst not effecting the viral load in a subject, the pentosan polysulfate acts to reduce inflammation in tissues, such as the muscles, and in the joints of a subject. In addition, cartilage damage in the joints may be reduced. The reduction in inflammation and/or cartilage damage acts to reduce the severe pain experienced by subjects suffering from alphavirus infections, such as Ross River virus, chikungunya virus and Barmah Forest virus.
Claims
exact text as granted — not AI-modified1 . A method of treating a subject having an alphavirus infection comprising administering parenterally by intra-articular or intra-muscular injection an amount of pentosan polysulfate or a salt thereof effective to reduce alphavirus induced inflammation and/or alphavirus induced cartilage damage in the subject.
2 . The method of claim 1 wherein the inflammation is in the joints and/or muscles.
3 . The method of claim 2 wherein the inflammation is in the joints.
4 . The method of claim 2 wherein the inflammation is in the muscles.
5 . The method of claim 2 wherein the inflammation is in the joints and the muscles.
6 . The method of claim 1 wherein the alphavirus is selected from the group consisting of Ross River virus, chikungunya virus and Barmah Forest virus.
7 . The method of claim 6 wherein the virus is Ross River virus.
8 . The method of claim 6 wherein the virus is chikungunya virus.
9 . The method of claim 6 wherein the virus is Barmah Forest virus.
10 . The method of claim 1 wherein administration is intra-articular.
11 . The method of claim 1 wherein administration is intra-muscular.
12 . The method of claim 1 wherein the pentosan polysulfate is the sodium salt.
13 . The method of claim 1 wherein administration is daily.
14 . The method of claim 1 wherein administration is twice daily.
15 . The method of claim 13 wherein the amount administered is within the range of from 0.5 to 5.0 mg/kg body weight of subject.
16 . The method of claim 15 wherein the amount is within the range of from 1.0 to 5.0 mg/kg body weight of subject.
17 . The method of claim 16 wherein the amount is within the range of from 2.0 to 5.0 mg/kg body weight of subject.
18 . The method claim 17 wherein the subject is a human.
19 - 20 . (cancelled)
21 . A method of treating a subject having an alphavirus infection selected from the group consisting of Ross River virus, chikungunya virus and Barmah Forest virus comprising administering daily parenterally by intra-articular or intra-muscular injection an amount of sodium pentosan polysulfate effective to reduce alphavirus induced inflammation and/or alphavirus induced cartilage damage in the subject.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.